RARA CRAFT DATABASE for FDA Medical Devices
510(k)K181307

FDA DEVICE FACTS

Zimmer Nexel Total Elbow, Connrad/Morrey Total Elbow

Zimmer, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJanuary 28, 2019PRODUCT CODEJDC

Indications for use

Coonrad/Morrey Total Elbow Indications include: post-traumatic lesions or bone loss contributing to elbow instability; ankylosed joints, especially in cases of bilateral ankylosis from causes other than sepsis; advanced rheumatoid or degenerative arthritis with incapacitating pain; revision arthroplasty, and instability or loss of motion when the degree of joint damage precludes less radical procedures. The candidate for total elbow arthroplasty should exhibit joint destruction which significantly compromises the activities of daily living. Patient with single joint involvement (generally those with traumatic or degenerative arthritis) or significant lower extremity disability which require walking aids are less amenable to treatment than patients with advanced and predominantly upper extremity involvement. If possible, elbow replacement should be done after hip or knee surgery to avoid excessive stress to the prosthesis required by crutch walking during total hip or knee rehabilitation. Zimmer Nexel Total Elbow Indications for use include:

- Elbow joint destruction which significantly compromises the ac tivities of daily living

- Post-traumatic lesions or bone loss contributing to elbow inst ability

- Ankylosed joints, especially in cases of bilateral ankylosis f rom causes other than active sepsis

- Advanced rheumatoid, post-traumatic, or degenerative arthritis with incapacitating pain

- Instability or loss of motion when the degree of joint or soft tissue damage precludes reliable osteosynthesis

- Acute comminuted articular fracture of the elbow joint surface s that precludes less radical procedures, including 13-C3 fractures of the distal humerus

- Revision arthroplasty Caution: This device is intended for cemented use only

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 26, 2026